Beta Bionics Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
423
- Stock Symbol
-
BBNX
- Share Price
-
$16.44
- (As of Friday Closing)
Beta Bionics General Information
Description
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Contact Information
Website
www.betabionics.comCorporate Office
- 11 Hughes
- Irvine, CA 92618
- United States
Corporate Office
- 11 Hughes
- Irvine, CA 92618
- United States
Beta Bionics Timeline
Beta Bionics Stock Performance
As of 13-Nov-2026, Beta Bionics’s stock price is $16.44. Its current market cap is $893M with 54.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.44 | $16.51 | $8.80 - $32.71 | $893M | 54.4M | 1.22M | -$1.84 |
Beta Bionics Financials Summary
As of 30-Sep-2026, Beta Bionics has a trailing 12-month revenue of $127M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 849,922 | 1,120,431 | ||
| Revenue | 127,265 | 100,251 | 65,124 | 11,995 |
| EBITDA | (88,239) | (81,257) | (56,382) | (43,785) |
| Net Income | (83,117) | (73,200) | (54,756) | (44,099) |
| Total Assets | 443,759 | 328,743 | 149,645 | 110,040 |
| Total Debt | 6,101 | 7,303 | 7,255 | 4,223 |
Beta Bionics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Beta Bionics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Beta Bionics Comparisons
Industry
Financing
Details
Beta Bionics Competitors (17)
One of Beta Bionics’s 17 competitors is ReTiSense, a Formerly Accelerator/Incubator backed company based in Bangalore, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ReTiSense | Formerly Accelerator/Incubator backed | Bangalore, India | ||||
| GlucoTrack Technologies | Corporate Backed or Acquired | Rutherford, NJ | ||||
| NeuroMetrix | Formerly VC-backed | Woburn, MA | ||||
| Baxter International | Corporation | Deerfield, IL | ||||
| PixCell Medical Technologies | Formerly VC-backed | Yokneam Ilit, Israel |
Beta Bionics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Beta Bionics Patents
Beta Bionics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260315690-A1 | Novel enhanced patch pump systems comprised of durables & disposables driven by improved form factors | Pending | 10-Apr-2025 | ||
| US-20260295150-A1 | Systems, methods, and devices for amublatory medicament administration | Pending | 27-Mar-2025 | ||
| US-20260257007-A1 | Systems, methods, and devices for ambulatory medicament administration | Pending | 03-Mar-2025 | ||
| US-20260232896-A1 | Enhanced patch pump set up | Pending | 11-Feb-2025 | ||
| US-20260108672-A1 | Novel enhanced patch pump systems | Pending | 17-Oct-2024 | A61M5/14248 |
Beta Bionics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Beta Bionics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Beta Bionics FAQs
-
When was Beta Bionics founded?
Beta Bionics was founded in 2015.
-
Where is Beta Bionics headquartered?
Beta Bionics is headquartered in Irvine, CA.
-
What is the size of Beta Bionics?
Beta Bionics has 423 total employees.
-
What industry is Beta Bionics in?
Beta Bionics’s primary industry is Therapeutic Devices.
-
Is Beta Bionics a private or public company?
Beta Bionics is a Public company.
-
What is Beta Bionics’s stock symbol?
The ticker symbol for Beta Bionics is BBNX.
-
What is the current stock price of Beta Bionics?
As of 13-Nov-2026 the stock price of Beta Bionics is $16.44.
-
What is the current market cap of Beta Bionics?
The current market capitalization of Beta Bionics is $893M.
-
What is Beta Bionics’s current revenue?
The trailing twelve month revenue for Beta Bionics is $127M.
-
Who are Beta Bionics’s competitors?
ReTiSense, GlucoTrack Technologies, NeuroMetrix, Baxter International, and PixCell Medical Technologies are some of the 17 competitors of Beta Bionics.
-
What is Beta Bionics’s annual earnings per share (EPS)?
Beta Bionics’s EPS for 12 months was -$1.84.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
